drugset / Trial / NCT06834490
Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate safety and efficacy of sequential treatment with Mexidol® in patients with chronic cerebral ischemia (CCI).
Timeline
- Start
- 2019-11-05
- Primary completion
- 2020-12-08
- Completion
- 2020-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EMOXYPINE | Small molecule | 250 mg | Intravenous |